Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

Diabetes Care. 2023 Apr 1;46(4):e89-e91. doi: 10.2337/dc22-1952.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bariatric Surgery* / adverse effects
  • Cardiovascular Diseases* / surgery
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / surgery
  • Duodenum / surgery
  • Gastric Bypass* / adverse effects
  • Humans
  • Obesity / complications
  • Obesity / surgery
  • Obesity, Morbid* / complications
  • Obesity, Morbid* / surgery
  • Risk Factors
  • Treatment Outcome